Aytu Biopharma AYTU
NASDAQ AYTU
$1.96 -0.05 (-2.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Long-Term Debt Repayments (2011 - 2026)

Updated

Aytu Biopharma's Long-Term Debt Repayments came in at $464,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $464,000 a year earlier and unchanged from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Long-Term Debt Repayments (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Long-Term Debt Repayments was $1.86 million, unchanged from FY2025.

  • Long-Term Debt Repayments carries a five-year compound annual growth rate of 13.9% (FY2021 to FY2026).
  • Going back by fiscal year, Long-Term Debt Repayments was $1.86 million in FY2025 (-88.2%), $15.72 million in FY2024, $96,000 in FY2023 (-99.4%) and $16.1 million in FY2022.
  • The five-year range for quarterly Long-Term Debt Repayments is -$73.56 million (fiscal Q3 2022) to $89.61 million (fiscal Q2 2022).
  • The fastest year-over-year change in Long-Term Debt Repayments over five years came in fiscal Q1 2023 (growth of 4.0%), and the weakest in fiscal Q4 2025 (a decline of 97.0%).
  • Business Quant data shows AYTU's Long-Term Debt Repayments at $464,000 (Q3 2026), $465,000 (Q2 2026) and $464,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Aytu Biopharma 24.31 Mn -91.36 Mn 10.41 Mn 464,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 464,000.00
Mar 31, 2026 464,000.00
Dec 31, 2025 465,000.00
Sep 30, 2025 464,000.00
Jun 30, 2025 464,000.00
Mar 31, 2025 464,000.00
Dec 31, 2024 465,000.00
Sep 30, 2024 464,000.00
Jun 30, 2024 15.65 Mn
Mar 31, 2024 25,000.00
Dec 31, 2023 23,000.00
Sep 30, 2023 22,000.00
Jun 30, 2023 23,000.00
Mar 31, 2023 73,000.00
Dec 31, 2022 -26,000.00
Sep 30, 2022 26,000.00
Jun 30, 2022 26,000.00
Mar 31, 2022 -73.56 Mn
Dec 31, 2021 89.61 Mn
Sep 30, 2021 25,000.00
API Access

Aytu Biopharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AYTU&period=max&api_key=YOUR_API_KEY